[
  {
    "ts": "2026-02-16T00:20:05+00:00",
    "headline": "FDA Flu Setback Tests Moderna’s mRNA Pipeline And Regulatory Assumptions",
    "summary": "FDA issues a surprise refusal to review Moderna's mRNA-based flu vaccine filing, despite earlier agreement on trial design. Decision is described as unprecedented, with no cited safety or efficacy concerns in the application. The vaccine is under review in Europe, Canada, and Australia, while the US process stalls. Moderna, listed as NasdaqGS:MRNA, is best known for its mRNA based Covid 19 vaccine and has been working to extend that platform into seasonal flu and other respiratory diseases...",
    "url": "https://finance.yahoo.com/news/fda-flu-setback-tests-moderna-002005117.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "fde45911-521d-3b90-9b3e-c85021a0cce4",
      "content": {
        "id": "fde45911-521d-3b90-9b3e-c85021a0cce4",
        "contentType": "STORY",
        "title": "FDA Flu Setback Tests Moderna’s mRNA Pipeline And Regulatory Assumptions",
        "description": "",
        "summary": "FDA issues a surprise refusal to review Moderna's mRNA-based flu vaccine filing, despite earlier agreement on trial design. Decision is described as unprecedented, with no cited safety or efficacy concerns in the application. The vaccine is under review in Europe, Canada, and Australia, while the US process stalls. Moderna, listed as NasdaqGS:MRNA, is best known for its mRNA based Covid 19 vaccine and has been working to extend that platform into seasonal flu and other respiratory diseases...",
        "pubDate": "2026-02-16T00:20:05Z",
        "displayTime": "2026-02-16T00:20:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lV6Oo0M_C3X63uXoBkpnwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KdbFtaQiMRVA6Enl712wNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-flu-setback-tests-moderna-002005117.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-flu-setback-tests-moderna-002005117.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]